<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39380736</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Opportunistic infections changed before and after SARS-CoV-2 infection in inflammatory bowel disease patients: a retrospective single-center study in China.</ArticleTitle><Pagination><StartPage>1461801</StartPage><MedlinePgn>1461801</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1461801</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2024.1461801</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">SARS-CoV-2 transmission has become a serious worldwide public health concern. However, there is currently insufficient data to determine whether SARS-CoV-2 infection would affect opportunistic infections in inflammatory bowel disease (IBD) patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A retrospective study included 451 IBD patients (294 UC and 157 CD). The IBD patients were divided into two groups: before SARS-CoV-2 infection and after SARS-CoV-2 infection, and outcomes were measured for these groups. The primary outcome was the presence and distribution of opportunistic infections. The secondary outcomes included factors associated with opportunistic infections, based on which a nomogram prediction model was developed and validated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">After SARS-CoV-2 infection, the proportion of IBD patients with opportunistic infections by <i>Clostridium difficile</i> (21.31% vs. 14.01%, <i>p</i> = 0.044) and Epstein-Barr virus (13.93% vs. 4.35%, <i>p</i> = 0.001) was significantly higher compared to that before. Conversely, the proportion of patients with hepatitis B virus (3.69% vs. 10.14%, <i>p</i> = 0.006) and herpes simplex virus type I (1.23% vs. 4.35%, <i>p</i> = 0.04) infections was significantly lower after the infection. Additionally, pre-SARS-CoV-2 infection factors associated with opportunistic infections in IBD include duration of illness, red blood cell count, the presence of comorbid chronic illnesses, and alcohol consumption, while post-SARS-CoV-2 infection, the primary risk factors involve corticosteroid use, red blood cell count, protein level, and high-sensitivity C-reactive protein.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">After the SARS-CoV-2 infection, there has been a shift in the occurrence of opportunistic infections among IBD patients. It might be attributed to the use of corticosteroids and also the strengthening of containment measures, heightened public health awareness, and widespread vaccination.</AbstractText><CopyrightInformation>Copyright © 2024 Fan, Zhou, Zhang, Liu, Wu, Shi, Lin and Liang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Fan</LastName><ForeName>Zhenzhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhou</LastName><ForeName>He</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiaqi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiaoning</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Tong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Yanting</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Junchao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Crohn’s disease</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">inflammatory bowel disease</Keyword><Keyword MajorTopicYN="N">nomogram</Keyword><Keyword MajorTopicYN="N">opportunistic infection</Keyword><Keyword MajorTopicYN="N">ulcerative colitis</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>4</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39380736</ArticleId><ArticleId IdType="pmc">PMC11460596</ArticleId><ArticleId IdType="doi">10.3389/fmed.2024.1461801</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhou H, Wang F, Wan J, Su S, Shi Y, Li X, et al. . Systematic review and Meta-analysis of observational studies on the effectiveness and safety of Ustekinumab among patients with inflammatory bowel disease in eastern and Western countries. J Clin Med. (2023) 12:1894. doi: 10.3390/jcm12051894, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12051894</ArticleId><ArticleId IdType="pmc">PMC10004158</ArticleId><ArticleId IdType="pubmed">36902681</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Ran Z, Jin M, Qian JM. Current status of opportunistic infection in inflammatory bowel disease patients in Asia: a questionnaire-based multicenter study. Gut Liver. (2022) 16:726–35. doi: 10.5009/gnl210217, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.5009/gnl210217</ArticleId><ArticleId IdType="pmc">PMC9474486</ArticleId><ArticleId IdType="pubmed">35611664</ArticleId></ArticleIdList></Reference><Reference><Citation>Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, Chinese Medical Association . Evidence-based consensus on opportunistic infections in inflammatory bowel disease. J Dig Dis. (2018) 19:54–65. doi: 10.1111/1751-2980.12578, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1751-2980.12578</ArticleId><ArticleId IdType="pubmed">29330905</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucharzik T, Ellul P, Greuter T, Rahier JF, Verstockt B, Abreu C, et al. . Ecco guidelines on the prevention, diagnosis, and Management of Infections in inflammatory bowel disease. J Crohns Colitis. (2021) 15:879–913. doi: 10.1093/ecco-jcc/jjab052, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ecco-jcc/jjab052</ArticleId><ArticleId IdType="pubmed">33730753</ArticleId></ArticleIdList></Reference><Reference><Citation>Šašala M, Majorová E, Vrzgula A, Fandáková I. Evaluation of invasive intra-abdominal candidiasis in Crohn disease at the time of surgery. Ann Coloproctol. (2020) 36:12–6. doi: 10.3393/ac.2018.10.15.2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3393/ac.2018.10.15.2</ArticleId><ArticleId IdType="pmc">PMC7069678</ArticleId><ArticleId IdType="pubmed">32146783</ArticleId></ArticleIdList></Reference><Reference><Citation>Axelrad JE, Cadwell KH, Colombel JF, Shah SC. Systematic review: gastrointestinal infection and incident inflammatory bowel disease. Aliment Pharmacol Ther. (2020) 51:1222–32. doi: 10.1111/apt.15770, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.15770</ArticleId><ArticleId IdType="pmc">PMC7354095</ArticleId><ArticleId IdType="pubmed">32372471</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (Covid-19): a review. JAMA. (2020) 324:782–93. doi: 10.1001/jama.2020.12839</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Payus AO, Mohd Noh M, Azizan N, Muthukaruppan CR. Sars-Cov-2-induced liver injury: a review article on the high-risk populations, manifestations, mechanisms, pathological changes, management, and outcomes. World J Gastroenterol. (2022) 28:5723–30. doi: 10.3748/wjg.v28.i39.5723, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v28.i39.5723</ArticleId><ArticleId IdType="pmc">PMC9627422</ArticleId><ArticleId IdType="pubmed">36338886</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Lin E, Hong X, Li L, Gu J, Zhao J, et al. . Klotho-derived peptide Kp1 ameliorates Sars-Cov-2-associated acute kidney injury. Front Pharmacol. (2023) 14:1333389. doi: 10.3389/fphar.2023.1333389, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2023.1333389</ArticleId><ArticleId IdType="pmc">PMC10795167</ArticleId><ArticleId IdType="pubmed">38239193</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada S, Hashita T, Yanagida S, Sato H, Yasuhiko Y, Okabe K, et al. . Sars-Cov-2 causes dysfunction in human Ipsc-derived brain microvascular endothelial cells potentially by modulating the Wnt signaling pathway. Fluids Barriers CNS. (2024) 21:32. doi: 10.1186/s12987-024-00533-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-024-00533-9</ArticleId><ArticleId IdType="pmc">PMC11000354</ArticleId><ArticleId IdType="pubmed">38584257</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong P, Xu J, Yang D, Shen Y, Wang L, Feng Y, et al. . Covid-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms. Signal Transduct Target Ther. (2020) 5:256. doi: 10.1038/s41392-020-00373-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00373-7</ArticleId><ArticleId IdType="pmc">PMC7605138</ArticleId><ArticleId IdType="pubmed">33139693</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukin DJ, Funez-de Pagnier G, Lima S, Lai D, Duenas-Bianchi L, Ahmed W, et al. . No durable impact of Covid-19 on intestinal disease activity in subjects with Ibd. Clin Gastroenterol Hepatol. (2021) 19:2312–2314.e3. doi: 10.1016/j.cgh.2021.06.008, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2021.06.008</ArticleId><ArticleId IdType="pmc">PMC8178538</ArticleId><ArticleId IdType="pubmed">34102340</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, et al. . Alterations in gut microbiota of patients with Covid-19 during time of hospitalization. Gastroenterology. (2020) 159:944–955.e8. doi: 10.1053/j.gastro.2020.05.048, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrino R, Pellino G, Selvaggi L, Selvaggi F, Federico A, Romano M, et al. . Bnt 162b2 Mrna Covid-19 vaccine is safe in a setting of patients on biologic therapy with inflammatory bowel diseases: a monocentric real-life study. Expert Rev Clin Pharmacol. (2022) 15:1243–52. doi: 10.1080/17512433.2022.2120466, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17512433.2022.2120466</ArticleId><ArticleId IdType="pubmed">36047032</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan N, Mahmud N, Patel M, Sundararajan R, Reinisch W. Risk of severe and opportunistic infections and the impact of Sars-Cov-2 on this risk in a Nationwide cohort of patients with inflammatory bowel disease. Aliment Pharmacol Ther. (2023) 57:800–7. doi: 10.1111/apt.17393, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.17393</ArticleId><ArticleId IdType="pmc">PMC10023400</ArticleId><ArticleId IdType="pubmed">36645110</ArticleId></ArticleIdList></Reference><Reference><Citation>Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, Chinese Medical Association . Chinese consensus on diagnosis and treatment in inflammatory bowel disease (2018, Beijing). J Dig Dis. (2021) 22:298–317. doi: 10.1111/1751-2980.12994, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1751-2980.12994</ArticleId><ArticleId IdType="pubmed">33905603</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahier JF, Magro F, Abreu C, Armuzzi A, Ben-Horin S, Chowers Y, et al. . Second European evidence-based consensus on the prevention, diagnosis and Management of Opportunistic Infections in inflammatory bowel disease. J Crohns Colitis. (2014) 8:443–68. doi: 10.1016/j.crohns.2013.12.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crohns.2013.12.013</ArticleId><ArticleId IdType="pubmed">24613021</ArticleId></ArticleIdList></Reference><Reference><Citation>Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, Chinese Medical Association . Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication). Intest Res. (2018) 16:178–93. doi: 10.5217/ir.2018.16.2.178, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.5217/ir.2018.16.2.178</ArticleId><ArticleId IdType="pmc">PMC5934591</ArticleId><ArticleId IdType="pubmed">29743831</ArticleId></ArticleIdList></Reference><Reference><Citation>Kevadiya BD, Machhi J, Herskovitz J, Oleynikov MD, Blomberg WR, Bajwa N, et al. . Diagnostics for Sars-Cov-2 infections. Nat Mater. (2021) 20:593–605. doi: 10.1038/s41563-020-00906-z, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41563-020-00906-z</ArticleId><ArticleId IdType="pmc">PMC8264308</ArticleId><ArticleId IdType="pubmed">33589798</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R, Wu R, Wang L, Yang H. Increasing ratio of opportunistic infections associated with sunshine exposure and economic level burdening Chinese inflammatory bowel disease hospitalized patients: the first Nationwide survey from 2014 to 2019. BMC Public Health. (2024) 24:133. doi: 10.1186/s12889-024-17635-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-024-17635-6</ArticleId><ArticleId IdType="pmc">PMC10777555</ArticleId><ArticleId IdType="pubmed">38195452</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewandowski K, Rosołowski M, Kaniewska M, Kucha P, Meler A, Wierzba W, et al. . Clostridioides difficile infection in coronavirus disease 2019 (Covid-19): an underestimated problem? Pol Arch Intern Med. (2021) 131:121–7. doi: 10.20452/pamw.15715, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.20452/pamw.15715</ArticleId><ArticleId IdType="pubmed">33314875</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Song J, Liu H, Zheng H, Chen C. Positive Epstein-Barr virus detection in coronavirus disease 2019 (Covid-19) patients. Sci Rep. (2021) 11:10902. doi: 10.1038/s41598-021-90351-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90351-y</ArticleId><ArticleId IdType="pmc">PMC8149409</ArticleId><ArticleId IdType="pubmed">34035353</ArticleId></ArticleIdList></Reference><Reference><Citation>Im JH, Nahm CH, Je YS, Lee JS, Baek JH, Kwon HY, et al. . The effect of Epstein-Barr virus viremia on the progression to severe Covid-19. Medicine (Baltimore). (2022) 101:e29027. doi: 10.1097/md.0000000000029027, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/md.0000000000029027</ArticleId><ArticleId IdType="pmc">PMC9276369</ArticleId><ArticleId IdType="pubmed">35550458</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan M, Xiao LY, Gosau M, Friedrich RE, Smeets R, Fu LL, et al. . The causal association between Covid-19 and herpes simplex virus: a Mendelian randomization study. Front Immunol. (2023) 14:1281292. doi: 10.3389/fimmu.2023.1281292, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1281292</ArticleId><ArticleId IdType="pmc">PMC10749317</ArticleId><ArticleId IdType="pubmed">38146366</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Z, Hao H, Bi X, Lin Y, Yang L, Wang S, et al. . Study on liver histopathology of chronic Hbv infected patients with different Normal alt values. Front Immunol. (2022) 13:1069752. doi: 10.3389/fimmu.2022.1069752, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1069752</ArticleId><ArticleId IdType="pmc">PMC9725112</ArticleId><ArticleId IdType="pubmed">36483546</ArticleId></ArticleIdList></Reference><Reference><Citation>Wingrove C, Ferrier L, James C, Wang S. The impact of Covid-19 on hepatitis elimination. Lancet Gastroenterol Hepatol. (2020) 5:792–4. doi: 10.1016/s2468-1253(20)30238-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2468-1253(20)30238-7</ArticleId><ArticleId IdType="pmc">PMC7384773</ArticleId><ArticleId IdType="pubmed">32730783</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghemo A, Masarone M, Montagnese S, Petta S, Ponziani FR, Russo FP. Assessing the impact of Covid-19 on the Management of Patients with liver diseases: a National Survey by the Italian Association for the Study of the liver. Dig Liver Dis. (2020) 52:937–41. doi: 10.1016/j.dld.2020.07.008, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2020.07.008</ArticleId><ArticleId IdType="pmc">PMC7351426</ArticleId><ArticleId IdType="pubmed">32703730</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkenthal TA, Aldaher Z, Ahmed S, DiValentin L. Autoimmune hemolytic Anemia exacerbation associated with Covid-19 infection and markedly elevated inflammatory markers. Cureus. (2021) 13:e20416. doi: 10.7759/cureus.20416, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.20416</ArticleId><ArticleId IdType="pmc">PMC8759712</ArticleId><ArticleId IdType="pubmed">35047256</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DW, Byeon KH, Kim J, Cho KD, Lee N. The correlation of comorbidities on the mortality in patients with Covid-19: an observational study based on the Korean National Health Insurance big Data. J Korean Med Sci. (2020) 35:e243. doi: 10.3346/jkms.2020.35.e243, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e243</ArticleId><ArticleId IdType="pmc">PMC7338208</ArticleId><ArticleId IdType="pubmed">32627443</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, Liu Y, Cheng Z, Yu X, Li Y. Covid-19-associated liver injury: clinical characteristics, pathophysiological mechanisms and treatment management. Biomed Pharmacother. (2022) 154:113568. doi: 10.1016/j.biopha.2022.113568, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.113568</ArticleId><ArticleId IdType="pmc">PMC9381432</ArticleId><ArticleId IdType="pubmed">36029543</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy NA, Jones GR, Lamb CA, Appleby R, Arnott I, Beattie RM, et al. . British Society of Gastroenterology Guidance for Management of Inflammatory Bowel Disease during the Covid-19 pandemic. Gut. (2020) 69:984–90. doi: 10.1136/gutjnl-2020-321244, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-321244</ArticleId><ArticleId IdType="pmc">PMC7211081</ArticleId><ArticleId IdType="pubmed">32303607</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas GD. Iron deficiency Anemia. Med Clin North Am. (2017) 101:319–32. doi: 10.1016/j.mcna.2016.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcna.2016.09.004</ArticleId><ArticleId IdType="pubmed">28189173</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerra I, Algaba A, Jiménez L, Mar Aller M, Garza D, Bonillo D, et al. . Incidence, clinical characteristics, and evolution of Sars-Cov-2 infection in patients with inflammatory bowel disease: a single-center study in Madrid, Spain. Inflamm Bowel Dis. (2021) 27:25–33. doi: 10.1093/ibd/izaa221, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ibd/izaa221</ArticleId><ArticleId IdType="pmc">PMC7499624</ArticleId><ArticleId IdType="pubmed">32830267</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren M, O'Connor C, Lee JE, Burton J, Walton D, Keathley J, et al. . Predispose, precipitate, perpetuate, and protect: how diet and the gut influence mental health in emerging adulthood. Front Nutr. (2024) 11:1339269. doi: 10.3389/fnut.2024.1339269, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2024.1339269</ArticleId><ArticleId IdType="pmc">PMC10948435</ArticleId><ArticleId IdType="pubmed">38505265</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte BA, Kelly MM, Shirk SD, Chamberlin ES, Reilly ED. A quantitative and qualitative examination of the impacts of the Covid-19 pandemic on U.S. veterans with self-reported anxiety and alcohol use disorder. Front Psychol. (2022) 13:1083212. doi: 10.3389/fpsyt.2022.1083212, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2022.1083212</ArticleId><ArticleId IdType="pmc">PMC9904239</ArticleId><ArticleId IdType="pubmed">36762293</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawada M, Ohkuma K, Aihara M, Doi S, Sekine R, Kaneko T, et al. . Impact of the Covid-19 pandemic on the glycemic control, eating habits, and body compositions of people with diabetes mellitus: a retrospective longitudinal observational study. J Diabetes Investig. (2023) 14:321-8. doi: 10.1111/jdi.13934, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdi.13934</ArticleId><ArticleId IdType="pmc">PMC9878046</ArticleId><ArticleId IdType="pubmed">36346131</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SI, Cho IY. Factors affecting parent health-promotion behavior in early childhood according to family cohesion: focusing on the Covid-19 pandemic. J Pediatr Nurs. (2022) 62:121–8. doi: 10.1016/j.pedn.2021.08.022, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pedn.2021.08.022</ArticleId><ArticleId IdType="pmc">PMC8423845</ArticleId><ArticleId IdType="pubmed">34507852</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Pan Y, Ding X, Aierken A, Jiang W. The effect of training medical students in the community area in the midst of the Covid-19 pandemic in China: a community-based study. BMC Med Educ. (2023) 23:517. doi: 10.1186/s12909-023-04509-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12909-023-04509-5</ArticleId><ArticleId IdType="pmc">PMC10354964</ArticleId><ArticleId IdType="pubmed">37464393</ArticleId></ArticleIdList></Reference><Reference><Citation>Brambilla B, Barbosa AM, Scholze CDS, Riva F, Freitas L, Balbinot RA, et al. . Hemophagocytic Lymphohistiocytosis and inflammatory bowel disease: case report and systematic review. Inflam Intest Dis. (2020) 5:49–58. doi: 10.1159/000506514, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000506514</ArticleId><ArticleId IdType="pmc">PMC7315217</ArticleId><ArticleId IdType="pubmed">32596254</ArticleId></ArticleIdList></Reference><Reference><Citation>Soldera J, Bosi GR. Haemophagocytic Lymphohistiocytosis following a Covid-19 infection: case report. J Infect Dev Count. (2023) 17:302–3. doi: 10.3855/jidc.16983, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.16983</ArticleId><ArticleId IdType="pubmed">37023430</ArticleId></ArticleIdList></Reference><Reference><Citation>Soldera J, Balbinot RA, Balbinot SS. Billiary casts in post-Covid-19. Gastroenterol Hepatol. (2023) 46:319–20. doi: 10.1016/j.gastre.2022.08.003.Epub</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gastre.2022.08.003.Epub</ArticleId><ArticleId IdType="pmc">PMC9476357</ArticleId><ArticleId IdType="pubmed">36116722</ArticleId></ArticleIdList></Reference><Reference><Citation>Graciolli AM, De Bortoli BR, Maslonek C, Gremelmier EMC, Henrich CF, Salgado K, et al. . Post-Covid-19 cholangiopathy. Digest Med Res. (2023) 6:29. doi: 10.21037/dmr-22-83</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/dmr-22-83</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasheed MA, Ballotin VR, Bigarella LG, Soldera J. Post-Covid-19 Cholangiopathy: systematic review. World J Methodol. (2023) 13:296–322. doi: 10.5662/wjm.v13.i4.296, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.5662/wjm.v13.i4.296</ArticleId><ArticleId IdType="pmc">PMC10523251</ArticleId><ArticleId IdType="pubmed">37771872</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>